Cognitive decline of stroke patients associated with amyloid-β deposition

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • PET-detected deposition of amyloid-β (Aβ) is associated with cognitive decline of stroke/transient ischemic attack patients.

Key results

  • Patients with Alzheimer’s disease (AD)-like Aβ deposition showed a significant decline in cognitive performance on the Mini-Mental State Examination (MMSE) (p=.020), while non-Aβ patients did not (p=.208).
  • Rates of cognitive decline were greater on the MMSE and Montreal Cognitive Assessment in Aβ patients compared with non-Aβ patients (p=.023 and p=.03, respectively).

Study design

  • 72 stroke/transient ischemic attack patients without AD were analyzed by PET for Aβ deposition and tested for cognitive impairments by the MMSE and Montreal Cognitive Assessment over 3 years.